Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 32

    1.

    Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia.

    Reungjui S, Pratipanawatr T, Johnson RJ, Nakagawa T.

    Curr Opin Nephrol Hypertens. 2008 Sep;17(5):470-6. Review.PMID: 18695387 [PubMed - indexed for MEDLINE]Related articles

    2.

    Thailand diabetes registry project: prevalence of vascular complications in long-standing type 2 diabetes.

    Leelawattana R, Pratipanawatr T, Bunnag P, Kosachunhanun N, Suwanwalaikorn S, Krittiyawong S, Chetthakul T, Plengvidhya N, Benjasuratwong Y, Deerochanawong C, Mongkolsomlit S, Ngarmukos C, Rawdaree P.

    J Med Assoc Thai. 2006 Aug;89 Suppl 1:S54-9.PMID: 17717878 [PubMed - indexed for MEDLINE]Related articles

    3.

    Thailand diabetes registry project: prevalence of hypertension, treatment and control of blood pressure in hypertensive adults with type 2 diabetes.

    Bunnag P, Plengvidhya N, Deerochanawong C, Suwanwalaikorn S, Kosachunhanun N, Benjasuratwong Y, Krittiyawong S, Leelawatana R, Pratipanawatr T, Ngarmukos C, Chetthakul T, Puavilai G, Mongkolsomlit S, Rawdaree P.

    J Med Assoc Thai. 2006 Aug;89 Suppl 1:S72-7.PMID: 17715837 [PubMed - indexed for MEDLINE]Related articles

    4.

    Thailand diabetes registry project: glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage.

    Kosachunhanun N, Benjasuratwong Y, Mongkolsomlit S, Rawdaree P, Plengvidhya N, Leelawatana R, Bunnag P, Pratipanawatr T, Krittiyawong S, Suwanwalaikorn S, Deerochanawong C, Chetthakul T, Ngarmukos C, Komoltri C.

    J Med Assoc Thai. 2006 Aug;89 Suppl 1:S66-71.PMID: 17715836 [PubMed - indexed for MEDLINE]Related articles

    5.

    Thailand diabetes registry project: current status of dyslipidemia in Thai diabetic patients.

    Pratipanawatr T, Rawdaree P, Chetthakul T, Bunnag P, Ngarmukos C, Benjasuratwong Y, Leelawatana R, Kosachunhanun N, Plengvidhya N, Deerochanawong C, Suwanwalaikorn S, Krittiyawong S, Mongkolsomlit S, Komoltri C.

    J Med Assoc Thai. 2006 Aug;89 Suppl 1:S60-5.PMID: 17715835 [PubMed - indexed for MEDLINE]Related articles

    6.

    Thailand diabetes registry project: prevalence and risk factors of stroke in thai diabetic patients.

    Plengvidhya N, Leelawatana R, Pratipanawatr T, Deerochanawong C, Krittiyawong S, Bunnag P, Kosachunhanun N, Suwanwalaikorn S, Benjasuratwong Y, Chetthakul T, Ngarmukos C, Vannasaeng S, Mongkolsomlit S, Komoltri C, Rawdaree P.

    J Med Assoc Thai. 2006 Aug;89 Suppl 1:S49-53.PMID: 17715834 [PubMed - indexed for MEDLINE]Related articles

    7.

    Thailand diabetes registry project: prevalence and risk factors associated with lower extremity amputation in Thai diabetics.

    Krittiyawong S, Ngarmukos C, Benjasuratwong Y, Rawdaree P, Leelawatana R, Kosachunhanun N, Plengvidhya N, Deerochanawong C, Suwanwalaikorn S, Pratipanawatr T, Chetthakul T, Mongkolsomlit S, Bunnag P.

    J Med Assoc Thai. 2006 Aug;89 Suppl 1:S43-8.PMID: 17715833 [PubMed - indexed for MEDLINE]Related articles

    8.

    Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 2 diabetes mellitus.

    Chetthakul T, Deerochanawong C, Suwanwalaikorn S, Kosachunhanun N, Ngarmukos C, Rawdaree P, Krittiyawong S, Leelawatana R, Bunnag P, Plengvidhya N, Pratipanawatr T, Benjasuratwong Y, Mongkolsomlit S.

    J Med Assoc Thai. 2006 Aug;89 Suppl 1:S27-36.PMID: 17715831 [PubMed - indexed for MEDLINE]Related articles

    9.

    Thailand diabetes registry project: type of diabetes, glycemic control and prevalence of microvascular complications in children and adolescents with diabetes.

    Likitmaskul S, Wacharasindhu S, Rawdaree P, Ngarmukos C, Deerochanawong C, Suwanwalaikorn S, Chetthakul T, Bunnag P, Kosachunhanun N, Plengvidhaya N, Leelawatana R, Krittiyawong S, Benjasuratwong Y, Pratipanawatr T.

    J Med Assoc Thai. 2006 Aug;89 Suppl 1:S10-6.PMID: 17715829 [PubMed - indexed for MEDLINE]Related articles

    10.

    Myasthenia gravis accompanied with hypokalemic periodic paralysis.

    Sawanyawisuth K, Tiamkao S, Pratipanawatr T.

    J Med Assoc Thai. 2006 May;89(5):727-9.PMID: 16756062 [PubMed - indexed for MEDLINE]Related articles

    11.

    Reduced skeletal muscle inhibitor of kappaB beta content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise training.

    Sriwijitkamol A, Christ-Roberts C, Berria R, Eagan P, Pratipanawatr T, DeFronzo RA, Mandarino LJ, Musi N.

    Diabetes. 2006 Mar;55(3):760-7.PMID: 16505240 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Prevalence of dyslipidemia in rural Thai adults: an epidemiologic study in Khon Kaen province.

    Pongchaiyakul C, Pongchaiyakul C, Pratipanawatr T.

    J Med Assoc Thai. 2005 Aug;88(8):1092-7.PMID: 16404837 [PubMed - indexed for MEDLINE]Related articles

    13.

    Increased collagen content in insulin-resistant skeletal muscle.

    Berria R, Wang L, Richardson DK, Finlayson J, Belfort R, Pratipanawatr T, De Filippis EA, Kashyap S, Mandarino LJ.

    Am J Physiol Endocrinol Metab. 2006 Mar;290(3):E560-5. Epub 2005 Oct 25.PMID: 16249255 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Dose-response effect of elevated plasma free fatty acid on insulin signaling.

    Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, Berria R, Defronzo RA, Cusi K.

    Diabetes. 2005 Jun;54(6):1640-8.PMID: 15919784 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects.

    Christ-Roberts CY, Pratipanawatr T, Pratipanawatr W, Berria R, Belfort R, Kashyap S, Mandarino LJ.

    Metabolism. 2004 Sep;53(9):1233-42.PMID: 15334390 [PubMed - indexed for MEDLINE]Related articles

    16.

    Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients.

    Bajaj M, Suraamornkul S, Hardies LJ, Pratipanawatr T, DeFronzo RA.

    Int J Obes Relat Metab Disord. 2004 Jun;28(6):783-9.PMID: 15024400 [PubMed - indexed for MEDLINE]Related articles

    17.

    Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.

    Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Jan;89(1):200-6.PMID: 14715850 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Ceramide content is increased in skeletal muscle from obese insulin-resistant humans.

    Adams JM 2nd, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC, Mandarino LJ.

    Diabetes. 2004 Jan;53(1):25-31.PMID: 14693694 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.

    Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K.

    Diabetes. 2003 Oct;52(10):2461-74.PMID: 14514628 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Seizures in nonketotic hyperglycaemia.

    Tiamkao S, Pratipanawatr T, Tiamkao S, Nitinavakarn B, Chotmongkol V, Jitpimolmard S.

    Seizure. 2003 Sep;12(6):409-10. No abstract available. PMID: 12915089 [PubMed - indexed for MEDLINE]Related articles

    21.

    Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action.

    Christ-Roberts CY, Pratipanawatr T, Pratipanawatr W, Berria R, Belfort R, Mandarino LJ.

    J Appl Physiol. 2003 Dec;95(6):2519-29. Epub 2003 Aug 8.PMID: 12909611 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.

    Bajaj M, Suraamornkul S, Pratipanawatr T, Hardies LJ, Pratipanawatr W, Glass L, Cersosimo E, Miyazaki Y, DeFronzo RA.

    Diabetes. 2003 Jun;52(6):1364-70.PMID: 12765945 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes.

    Bajaj M, Pratipanawatr T, Berria R, Pratipanawatr W, Kashyap S, Cusi K, Mandarino L, DeFronzo RA.

    Diabetes. 2002 Oct;51(10):3043-8.PMID: 12351445 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans.

    Bajaj M, Berria R, Pratipanawatr T, Kashyap S, Pratipanawatr W, Belfort R, Cusi K, Mandarino L, DeFronzo RA.

    Am J Physiol Endocrinol Metab. 2002 Aug;283(2):E346-52.PMID: 12110541 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Effect of misoprostol (PGE1) on glucose metabolism in type-2-diabetic and control subjects.

    Lee NA, Matsuda M, Bressler P, Pratipanawatr T, Glass L, Mandarino LJ, DeFronzo RA.

    Diabetes Obes Metab. 2002 May;4(3):195-200.PMID: 12047398 [PubMed - indexed for MEDLINE]Related articles

    26.

    Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.

    Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA.

    Am J Physiol Endocrinol Metab. 2002 Jun;282(6):E1360-8.PMID: 12006367 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes.

    Pratipanawatr T, Cusi K, Ngo P, Pratipanawatr W, Mandarino LJ, DeFronzo RA.

    Diabetes. 2002 Feb;51(2):462-8.PMID: 11812756 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation.

    Pratipanawatr W, Pratipanawatr T, Cusi K, Berria R, Adams JM, Jenkinson CP, Maezono K, DeFronzo RA, Mandarino LJ.

    Diabetes. 2001 Nov;50(11):2572-8.PMID: 11679436 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Exercise increases hexokinase II mRNA, but not activity in obesity and type 2 diabetes.

    Cusi KJ, Pratipanawatr T, Koval J, Printz R, Ardehali H, Granner DK, Defronzo RA, Mandarino LJ.

    Metabolism. 2001 May;50(5):602-6.PMID: 11319725 [PubMed - indexed for MEDLINE]Related articles

    30.

    Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis.

    Iozzo P, Pratipanawatr T, Pijl H, Vogt C, Kumar V, Pipek R, Matsuda M, Mandarino LJ, Cusi KJ, DeFronzo RA.

    Am J Physiol Endocrinol Metab. 2001 May;280(5):E712-9.PMID: 11287353 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Regulation of MAP kinase pathway activity in vivo in human skeletal muscle.

    Osman AA, Pendergrass M, Koval J, Maezono K, Cusi K, Pratipanawatr T, Mandarino LJ.

    Am J Physiol Endocrinol Metab. 2000 Jun;278(6):E992-9.PMID: 10827000 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.

    Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR, Mandarino LJ.

    J Clin Invest. 2000 Feb;105(3):311-20.PMID: 10675357 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...